Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideo Yagita

Showing results (1-10 of 589) with videos related to

Pageof 59
Sort By:
Biochemical and Biophysical Research Communications|February 23, 2010
Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent miceTamami Sakanishi, Hideo Yagita
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2014
Macrophage-derived delta-like protein 1 enhances interleukin-6 and matrix metalloproteinase 3 production by fibroblast-like synoviocytes in mice with collagen-induced arthritisChiyoko Sekine, Toshihiro Nanki, Hideo Yagita
Biochemical and Biophysical Research Communications|February 8, 2012
Expression of Notch receptors and ligands on immature and mature T cellsAkemi Koyanagi, Chiyoko Sekine, Hideo Yagita
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cellsTimothy N J Bullock, Hideo Yagita
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cellsAmanda L Marzo, Hideo Yagita, Leo Lefrançois
Frontiers in Oncology|April 1, 2025
IL-18-primed NK cells recruit dendritic cells and potentiate tumor therapy mediated by PD-1 blockadeYoshiya Ohno, Haruki Okamura, Hideo Yagita, et al.
The Journal of Experimental Medicine|May 19, 2004
T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosisZhenyue Hao, Brigitte Hampel, Hideo Yagita, et al.
Trends in Molecular Medicine|July 2, 2013
Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cellsMasahisa Jinushi, Hideo Yagita, Hironori Yoshiyama, et al.
Biochemical and Biophysical Research Communications|June 25, 2003
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodiesMasafumi Nakayama, Norihiro Harada, Ko Okumura, et al.
Journal of Leukocyte Biology|August 19, 2004
Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium aviumManuela Flórido, Margarida Borges, Hideo Yagita, et al.
Pageof 59

Showing results (1-10 of 589) with videos related to

Sort By:
Pageof 59
Biochemical and Biophysical Research Communications|February 23, 2010
Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent miceTamami Sakanishi, Hideo Yagita
Arthritis & Rheumatology (Hoboken, N.J.)|June 20, 2014
Macrophage-derived delta-like protein 1 enhances interleukin-6 and matrix metalloproteinase 3 production by fibroblast-like synoviocytes in mice with collagen-induced arthritisChiyoko Sekine, Toshihiro Nanki, Hideo Yagita
Biochemical and Biophysical Research Communications|February 8, 2012
Expression of Notch receptors and ligands on immature and mature T cellsAkemi Koyanagi, Chiyoko Sekine, Hideo Yagita
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cellsTimothy N J Bullock, Hideo Yagita
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cellsAmanda L Marzo, Hideo Yagita, Leo Lefrançois
Frontiers in Oncology|April 1, 2025
IL-18-primed NK cells recruit dendritic cells and potentiate tumor therapy mediated by PD-1 blockadeYoshiya Ohno, Haruki Okamura, Hideo Yagita, et al.
The Journal of Experimental Medicine|May 19, 2004
T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosisZhenyue Hao, Brigitte Hampel, Hideo Yagita, et al.
Trends in Molecular Medicine|July 2, 2013
Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cellsMasahisa Jinushi, Hideo Yagita, Hironori Yoshiyama, et al.
Biochemical and Biophysical Research Communications|June 25, 2003
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodiesMasafumi Nakayama, Norihiro Harada, Ko Okumura, et al.
Journal of Leukocyte Biology|August 19, 2004
Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium aviumManuela Flórido, Margarida Borges, Hideo Yagita, et al.
Pageof 59